Medpace reports Q4/FY2025 results; specific figures unavailable from filing

Medpace Holdings, Inc.

2025-FY EPS reported $15.28 revenue$2,530,234,000

Press release issued Feb 9, 2026 for quarter and year ended Dec 31, 2025.
No financial details or guidance changes provided in the 8-K body.
Exhibit 99.1 containing actual results is referenced but not appended in this text.

item 2.02 item 9.01

Medpace Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001668397-26-000004

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.